Identifying plasma metabolic characteristics of major depressive disorder, bipolar disorder, and schizophrenia in adolescents

Identifying plasma metabolic characteristics of major depressive disorder, bipolar disorder, and schizophrenia in adolescents

Abstract Major depressive disorder (MDD), bipolar disorder (BD), and schizophrenia (SCZ) are classified as major mental disorders and together account for the second-highest global disease burden, and half of these patients experience symptom onset in adolescence. Several studies have reported both...

Full description

Bibliographic Details
Main Authors:	Bangmin Yin, Yuping Cai, Teng Teng, Xiaolin Wang, Xueer Liu, Xuemei Li, Jie Wang, Hongyan Wu, Yuqian He, Fandong Ren, Tianzhang Kou, Zheng-Jiang Zhu, Xinyu Zhou
Format:	Article
Language:	English
Published:	Nature Publishing Group 2024-03-01
Series:	Translational Psychiatry
Online Access:	https://doi.org/10.1038/s41398-024-02886-z

Similar Items

Identification of Sex-Specific Plasma Biomarkers Using Metabolomics for Major Depressive Disorder in Children and Adolescents
by: Yuanliang Jiang, et al.
Published: (2022-07-01)

Mitochondrial variants in schizophrenia, bipolar disorder, and major depressive disorder.
by: Brandi Rollins, et al.
Published: (2009-01-01)

Integrated pathophysiology of schizophrenia, major depression, and bipolar disorder as monoamine axon disorder
by: Shoji Nakamura
Published: (2022-01-01)

The Relationship Between Cognitive Dysfunction and Symptom Dimensions Across Schizophrenia, Bipolar Disorder, and Major Depressive Disorder
by: Yue Zhu, et al.
Published: (2019-04-01)

Temporal changes of gene expression in health, schizophrenia, bipolar disorder, and major depressive disorder
by: Arsen Arakelyan, et al.
Published: (2024-02-01)

Shared and distinct functional connectivity of hippocampal subregions in schizophrenia, bipolar disorder, and major depressive disorder
by: Yanzhuo Song, et al.
Published: (2022-09-01)

Decreased plasma neuropeptides in first-episode schizophrenia, bipolar disorder, major depressive disorder: associations with clinical symptoms and cognitive function
by: Hua Yu, et al.
Published: (2023-05-01)

Integrating proteomic and clinical data to discriminate major psychiatric disorders: Applications for major depressive disorder, bipolar disorder, and schizophrenia
by: Dongyoon Shin, et al.
Published: (2022-06-01)

Classification for psychiatric disorders including schizophrenia, bipolar disorder, and major depressive disorder using machine learning
by: Qingxia Yang, et al.
Published: (2022-01-01)

Anhedonia difference between major depressive disorder and bipolar disorder II
by: Xinyu Fang, et al.
Published: (2021-10-01)

Plasma neuropeptide levels in patients with schizophrenia, bipolar disorder, or major depressive disorder and healthy controls: A multiplex immunoassay study
by: Shinsuke Hidese, et al.
Published: (2023-03-01)

Classification of schizophrenia, bipolar disorder and major depressive disorder with comorbid traits and deep learning algorithms
by: Xiangning Chen, et al.
Published: (2025-02-01)

Prevalence of smoking in patients with bipolar disorder, major depressive disorder and schizophrenia and their relationships with quality of life
by: Xiao-Hong Li, et al.
Published: (2017-08-01)

Volumes of hippocampal subfields suggest a continuum between schizophrenia, major depressive disorder and bipolar disorder
by: Peiyu Cao, et al.
Published: (2023-07-01)

Alterations of Plasma Lipids in Adult Women With Major Depressive Disorder and Bipolar Depression
by: Ting Zhang, et al.
Published: (2022-07-01)

Cognitive Effects of Electroconvulsive Therapy in Patients with Major Depressive, Bipolar and Schizophrenia Disorders
by: N Fouladi, et al.
Published: (2011-10-01)

Identifying transdiagnostic biological subtypes across schizophrenia, bipolar disorder, and major depressive disorder based on lipidomics profiles
by: Shiwan Tao, et al.
Published: (2022-09-01)

Construction and analysis of the protein-protein interaction networks for schizophrenia, bipolar disorder, and major depression
by: Lee Sheng-An, et al.
Published: (2011-11-01)

Altered Fractional Amplitude of Low-Frequency Fluctuation in Major Depressive Disorder and Bipolar Disorder
by: Yan Qiu, et al.
Published: (2021-10-01)

Advances in the knowledge and therapeutics of schizophrenia, major depression disorder, and bipolar disorder from human brain organoid research
by: Rosa Villanueva
Published: (2023-07-01)

Comparison of insight in patients with schizophrenia, bipolar I disorder, and major depressive disorder in a real-world setting
by: Si-Sheng Huang, et al.
Published: (2019-01-01)

Subcortical Brain Volumes Relate to Neurocognition in First-Episode Schizophrenia, Bipolar Disorder, Major Depression Disorder, and Healthy Controls
by: Jing Shi, et al.
Published: (2022-01-01)

Alterations in Plasma Lipidomic Profiles in Adult Patients with Schizophrenia and Major Depressive Disorder
by: Fei Wang, et al.
Published: (2022-10-01)

Editorial: Genetic Mechanisms of Biomarkers in Schizophrenia, Bipolar Disorder and Depression
by: Yiguo Tang, et al.
Published: (2021-08-01)

Effect of antidepressants on functioning and quality of life outcomes in children and adolescents with major depressive disorder: a systematic review and meta-analysis
by: Teng Teng, et al.
Published: (2022-05-01)

Expression of POU-domain transcription factor, Oct-6, in schizophrenia, bipolar disorder and major depression
by: Price Jack, et al.
Published: (2005-10-01)

Slower and Less Variable Binocular Rivalry Rates in Patients With Bipolar Disorder, OCD, Major Depression, and Schizophrenia
by: Xing Ye, et al.
Published: (2019-05-01)

Discrepancy of social cognition between bipolar disorders and major depressive disorders
by: Yun‐Hsuan Chang, et al.
Published: (2024-01-01)

Inflammatory mediators in major depression and bipolar disorder
by: Sara Poletti, et al.
Published: (2024-06-01)

A diagnostic model based on bioinformatics and machine learning to differentiate bipolar disorder from schizophrenia and major depressive disorder
by: Jing Shen, et al.
Published: (2024-02-01)

Serum ceruloplasmin-ferroxidase activity in bipolar disorder is elevated compared to major depressive disorder and schizophrenia: a controlled study
by: Serhat Tunç, et al.
Published: (2019-07-01)

Exploring the role of serum uric acid as a biomarker in patients with schizophrenia, bipolar affective disorder, and major depressive disorder
by: Nermin Mahmoud Shaker, et al.
Published: (2023-04-01)

Using summary data from the Danish National Registers to estimate heritabilities for schizophrenia, bipolar disorder and major depressive disorder
by: Naomi R Wray, et al.
Published: (2012-07-01)

Bipolar disorders and schizophrenia: discrete disorders?
by: Micaela Dines, et al.
Published: (2024-04-01)

Quality of life in euthymic patients with unipolar major depressive disorder and bipolar disorder
by: Bo Q, et al.
Published: (2019-06-01)

Electroencephalographic Microstates in Schizophrenia and Bipolar Disorder
by: Fanglan Wang, et al.
Published: (2021-02-01)

Differentiation between bipolar disorder and major depressive disorder in adolescents: from clinical to biological biomarkers
by: Ruilan Yang, et al.
Published: (2023-09-01)

Progranulin gene variability and plasma levels in bipolar disorder and schizophrenia.
by: Daniela Galimberti, et al.
Published: (2012-01-01)

Utility of TEMPS-A in differentiation between major depressive disorder, bipolar I disorder, and bipolar II disorder.
by: Chihiro Morishita, et al.
Published: (2020-01-01)

The Role of Base Excision Repair in Major Depressive Disorder and Bipolar Disorder
by: M. Kucuker, et al.
Published: (2022-06-01)